## HAL: Halliburton Company - XLE: Energy

### Executive Summary

No thesis match: MRS_20 1.5% below STRENGTH zone (4.0-10.0%); PEG 11.42 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-4.0% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($25.69)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 9
- **Sentiment:** Neutral (Bullish: 0, Bearish: 2)

**1. Arabian Gulf Oil Company discusses technology support with Halliburton**
- Source: The Libya Observer | 20251217T140807 | Somewhat-Bullish | Relevance: 100%
- The Arabian Gulf Oil Company (AGOCO) has met with US firm Halliburton to discuss enhancing oil field operations through modern technology. The discussions focused on improving efficiency and increasing production across AGOCO's fields and facilities, aligning with plans to develop Libya's oil sector. Both parties also explored advanced drilling and production technologies to ensure sustainable oil operations.

**2. Halliburton (HAL) Declines More Than Market: Some Information for Investors**
- Source: www.sharewise.com | 20251217T030929 | Neutral | Relevance: 100%
- Halliburton (HAL) shares recently declined by 4.29%, underperforming the S&P 500. Despite this, the stock has gained 6.72% over the past month, surpassing the Oils-Energy sector. Investors are anticipating Halliburton's upcoming earnings report on January 21, 2026, with projected EPS of $0.54 and revenue of $5.39 billion.

**3. Halliburton Co. stock underperforms Tuesday when compared to competitors**
- Source: MarketWatch | 20251216T163000 | Bearish | Relevance: 100%
- Halliburton Co. (HAL) stock declined by 4.29% on Tuesday, closing at $27.19 amidst a general market downturn. The S&P 500 Index and Dow Jones Industrial Average also experienced losses, making it the third consecutive day of losses for Halliburton.

**4. B. Riley Wealth Advisors Inc. Purchases New Shares in Halliburton Company $HAL**
- Source: MarketBeat | 20251217T090825 | Somewhat-Bullish | Relevance: 100%
- B. Riley Wealth Advisors Inc. acquired a new stake of 37,404 shares in Halliburton Company (NYSE:HAL) during Q2, valued at approximately $762,000, contributing to an institutional ownership of about 85.23%. Halliburton recently surpassed quarterly earnings and revenue estimates, reporting EPS of $0.58 and revenue of $5.60 billion, with a consensus "Moderate Buy" rating and a target price of $32.41 from Wall Street analysts. The company also declared a quarterly dividend of $0.17, while insider transactions show some selling activity, including Mark Richard's sale of 160,000 shares.

**5. Barclays Raises Halliburton (NYSE:HAL) Price Target to $30.00**
- Source: MarketBeat | 20251216T150813 | Somewhat-Bullish | Relevance: 100%
- Barclays has increased its price target for Halliburton (NYSE:HAL) to $30.00 from $25.00, maintaining an "equal weight" rating, which suggests a potential 7.24% upside. This adjustment follows Halliburton's recent earnings beat, with EPS of $0.58 and revenue of $5.60 billion, exceeding expectations despite a slight year-over-year revenue decrease. Analyst consensus for Halliburton remains largely bullish, with a "Moderate Buy" rating and a consensus price target of $32.41.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 4, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-18 | Piper Sandler | $29 | $27 | +7% |
| 2025-12-17 | Barclays | $30 | $25 | +20% |
| 2025-12-12 | UBS | $32 | $24 | +33% |
| 2025-12-11 | Citigroup | $33 | $31 | +6% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-18 | Piper Sandler | main | Neutral |
| 2025-12-17 | Barclays | main | Equal-Weight |
| 2025-12-12 | UBS | main | Neutral |
| 2025-12-11 | Citigroup | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 10 ($0.00M) |
| Sells | 10 ($5.94M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 53.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 6 |

**Top Holders:**
- Vanguard Group Inc: 12.4% (-0.8%)
- Capital Research Glo: 10.8% (+81.8%)
- Blackrock Inc.: 9.7% (-1.2%)
- State Street Corpora: 5.9% (-3.9%)
- Charles Schwab Inves: 3.6% (+1.2%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-4.0% 5d) with bearish MACD, trend may be turning.
2. Insider selling cluster: $5.9M in recent transactions.
3. Valuation stretched: PEG 11.4x requires aggressive growth execution.

### Catalysts

- Analyst target momentum: 4 raises (avg +17%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.

### Fundamentals

PEG ratio 11.42 signals overvaluation risk, limited margin of safety. Analyst sentiment positive (4 raises, avg +17%). Insider selling cluster ($5.9M in 90 days), potential headwind. Institutional flow bullish (4 buying vs 6 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $23.4B |
| Beta | 0.82 |
| 52W Range | $18.72 - $30.40 |
| Short Interest | 3.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 11.42 |
| Forward P/E | 12.4 |
| Current P/E | 12.2 |
| YoY Growth | -1.6% |
| EPS Direction | RISING |

### Technicals

MRS_20 deteriorating from 5.5% to 1.5% (-4.0% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 2.5pp (needs >4.0% for momentum thesis). MRS_5 (-1.5%) diverging from MRS_20 - short-term weakness emerging. Outperforming sector by 3.1pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 51. OFD pattern: -SBL (Volatile).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 1.51% (CS: 55) | Neutral |
| RSI_14 | 51.2 | Neutral |
| MACD Histogram | -0.09 | Bearish |
| vs SMA20 | 1.005x | Above |
| vs SMA50 | 1.041x | Above |
| vs SMA200 | 1.185x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $27.45
- **Stop Loss:** $25.69 (6.4% risk)
- **Target:** $29.21 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 269
- **Position Value:** $7,384.05
- **Portfolio %:** 7.38%
- **Risk Dollars:** $475.00
- **Risk Per Trade:** 0.47%
- **Modifiers:** L1 95% | L2 50% | Combined 0.47x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with cautious positioning ahead of CPI data. VIX at moderate 16.87 with positive yield curve suggesting stable growth, but narrow breadth at 51.8% indicates selective participation. Banking sector optimism and corporate resilience provide support, though AI volatility creates pockets of uncertainty.*

### Earnings

**Next:** 2026-01-21 (Est: $0.53)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.50 | $0.58 | +16.9% |
| 2025Q2 | $0.55 | $0.55 | -0.7% |
| 2025Q1 | $0.60 | $0.60 | -0.4% |
| 2024Q4 | $0.70 | $0.70 | +0.7% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*